Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Medicine International
Join Editorial Board Propose a Special Issue
Print ISSN: 2754-3242 Online ISSN: 2754-1304
Journal Cover
May-June 2023 Volume 3 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-June 2023 Volume 3 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit

  • Authors:
    • Nicoleta-Dorina Vlad
    • Elena Dumea
    • Claudia-Simona Cambrea
    • Cristina Gabriela Puscasu
    • Constantin Ionescu
    • Bianca Averian
    • Raluca-Vasilica Mihai
    • Andrei Dumitru
    • Irina-Magdalena Dumitru
  • View Affiliations / Copyright

    Affiliations: Clinical Infectious Diseases Hospital of Constanta, 900709 Constanța, Romania, Faculty of Dentistry, Ovidius University of Constanța, 900470 Constanta, Romania, Faculty of Medicine, Ovidius University of Constanța, 900470 Constanta, Romania, Doctoral School of Medicine, Ovidius University of Constanța, 900470 Constanta, Romania
    Copyright: © Vlad et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 30
    |
    Published online on: June 14, 2023
       https://doi.org/10.3892/mi.2023.90
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Carbapenemase‑producing Enterobacterales (CPE) are Gram‑negative bacteria that belong to the Enterobacterales family and produce enzymes known as carbapenemases, which inhibit carbapenems, cephalosporins and penicillins. Carbapenem‑resistant Enterobacterales (CRE) are resistant to carbapenems, cephalosporins and penicillins via mechanisms that may or may not produce carbapenemases. The identification of carbapenems is critical for the initiation of proper antibiotic therapy. The present case‑control, retrospective study included 64 patients with CPE strains admitted to an intensive care unit between September, 2017 and October, 2021; of these, 34 patients with CPE succumbed and 30 control patients with CPE strains survived. CPE strains in the deceased patients were caused by Klebsiella spp. in 31 cases (91.2%) and Escherichia coli in 3 cases (8.8%). The univariate analysis revealed that the predictive factors associated with mortality in patients with CPE were admission with coronavirus disease 2019 (COVID‑19) (P=0.001), invasive mechanical ventilation (P=0.001), and treatment with corticosteroids (P=0.006). The multivariate analysis revealed that admission with COVID‑19 [odds ratio (OR), 16.26; 95% confidence interval (CI), 3.56‑74.14; P≤0.05] and invasive mechanical ventilation (OR, 14.98; 95% CI, 1.35‑166.22; P≤0.05) were associated with mortality as independent risk factors. Admission with COVID‑19 increased the risk of mortality 16.26‑fold and invasive mechanical ventilation increased the risk of mortality by 14.98‑fold. On the whole, the present study demonstrates that the length of hospital duration in patients who acquired CPE did not influence mortality, whereas infection with COVID‑19 increased and invasive mechanical ventilation were associated with an increased risk of mortality.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

European Centre for Disease Prevention and Control (ECDC). Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm, 2011.

2 

European Centre for Disease Prevention and Control (ECDC). Carbapenem-resistant Enterobacteriaceae, second update-26 September 2019. Stockholm, 2019.

3 

Segagni Lusignani L, Presterl E, Zatorska B, Van den Nest M and Diab-Elschahawi M: Infection control and risk factors for acquisition of carbapenemase-producing Enterobacteriaceae. A 5 year (2011-2016) case-control study. Antimicrob Resist Infect Control. 9(18)2020.PubMed/NCBI View Article : Google Scholar

4 

Kim YA, Lee SJ, Park YS, Lee YJ, Yeon JH, Seo YH and Lee K: Risk factors for carbapenemase-producing enterobacterales infection or colonization in a korean intensive care unit: A case-control study. Antibiotics (Basel). 9(680)2020.PubMed/NCBI View Article : Google Scholar

5 

Dumitru IM, Dumitrascu M, Vlad ND, Cernat RC, Ilie-Serban C, Hangan A, Slujitoru RE, Gherghina A, Mitroi-Maxim C, Curtali L, et al: Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19. Antibiotics (Basel). 10(561)2021.PubMed/NCBI View Article : Google Scholar

6 

WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2022-2020 data. Copenhagen, 2022.

7 

van Duin D and Doi Y: The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 8:460–469. 2017.PubMed/NCBI View Article : Google Scholar

8 

Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, Parsons D, Brannigan ET, Robotham J and Holmes AH: Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: An economic evaluation from a hospital perspective. Clin Microbiol Infect. 23:188–196. 2017.PubMed/NCBI View Article : Google Scholar

9 

Zhao S, Kennedy S, Perry MR, Wilson J, Chase-Topping M, Anderson E, Woolhouse MEJ and Lockhart M: Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities. J Hosp Infect. 110:184–193. 2021.PubMed/NCBI View Article : Google Scholar

10 

Pintado V, Ruiz-Garbajosa P, Escudero-Sanchez R, Gioia F, Herrera S, Vizcarra P, Fortún J, Cobo J, Martín-Dávila P, Morosini MI, et al: Carbapenemase-producing enterobacterales infections in COVID-19 patients. Infect Dis (Lond). 54:36–45. 2022.PubMed/NCBI View Article : Google Scholar

11 

Hu Q, Chen J, Sun S and Deng S: Mortality-related risk factors and novel antimicrobial regimens for carbapenem-resistant Enterobacteriaceae infections: A systematic review. Infect Drug Resist. 15:6907–6926. 2022.PubMed/NCBI View Article : Google Scholar

12 

European Centre for Disease Prevention and Control (ECDC). ECDC country visit to Romania to discuss antimicrobial resistance issues. Stockholm, 2018.

13 

World Medical Association. World medical association. World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 310:2191–2194. 2013.PubMed/NCBI View Article : Google Scholar

14 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC and Vandenbroucke JP: STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann Intern Med. 147:573–577. 2007.PubMed/NCBI View Article : Google Scholar

15 

Serpa Neto A, Deliberato RO, Johnson AEW, Bos LD, Amorim P, Pereira SM, Cazati DC, Cordioli RL, Correa TD, Pollard TJ, et al: Mechanical power of ventilation is associated with mortality in critically ill patients: An analysis of patients in two observational cohorts. Intensive Care Med. 44:1914–1922. 2018.PubMed/NCBI View Article : Google Scholar

16 

Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, Ambretti S, Pensalfine G, Appolloni L, Bartoletti M, et al: Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol. 43:461–466. 2022.PubMed/NCBI View Article : Google Scholar

17 

Contou D, Cally R, Sarfati F, Desaint P, Fraissé M and Plantefève G: Causes and timing of death in critically ill COVID-19 patients. Crit Care. 25(79)2021.PubMed/NCBI View Article : Google Scholar

18 

Kalın BS, Özçaylak S, Solmaz İ and Kılıç J: Assessment of risk factors for mortality in patients in medical intensive care unit of a tertiary hospital. Indian J Crit Care Med. 26:49–52. 2022.PubMed/NCBI View Article : Google Scholar

19 

Hughes LD, Aljawadi A and Pillai A: An overview of carbapenemase producing Enterobacteriaceae (CPE) in trauma and orthopaedics. J Orthop. 16:455–458. 2019.PubMed/NCBI View Article : Google Scholar

20 

Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M and Daikos GL: Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 20:862–872. 2014.PubMed/NCBI View Article : Google Scholar

21 

Mariappan S, Sekar U and Kamalanathan A: Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes. Int J Appl Basic Med Res. 7:32–39. 2017.PubMed/NCBI View Article : Google Scholar

22 

Moitra VK, Guerra C, Linde-Zwirble WT and Wunsch H: Relationship between ICU length of stay and long-term mortality for elderly ICU survivors. Crit Care Med. 44:655–662. 2016.PubMed/NCBI View Article : Google Scholar

23 

Williams TA, Ho KM, Dobb GJ, Finn JC, Knuiman M and Webb SA: Royal Perth Hospital ICU Data Linkage Group. Effect of length of stay in intensive care unit on hospital and long-term mortality of critically ill adult patients. Br J Anaesth. 104:459–464. 2010.PubMed/NCBI View Article : Google Scholar

24 

Rokni M, Ahmadikia K, Asghari S, Mashaei S and Hassanali F: Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: Diagnostic role of inflammatory indications in determining the severity of illness. BMC Infect Dis. 20(869)2020.PubMed/NCBI View Article : Google Scholar

25 

Ali M, Naureen H, Tariq MH, Farrukh MJ, Usman A, Khattak S and Ahsan H: Rational use of antibiotics in an intensive care unit: A retrospective study of the impact on clinical outcomes and mortality rate. Infect Drug Resist. 12:493–499. 2019.PubMed/NCBI View Article : Google Scholar

26 

Pinte L, Ceasovschih A, Niculae CM, Stoichitoiu LE, Ionescu RA, Balea MI, Cernat RC, Vlad N, Padureanu V, Purcarea A, et al: Antibiotic prescription and in-hospital mortality in COVID-19: A prospective multicentre cohort study. J Pers Med. 12(877)2022.PubMed/NCBI View Article : Google Scholar

27 

Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT and Daikos GL: Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev. 25:682–707. 2012.PubMed/NCBI View Article : Google Scholar

28 

Sherry NL, Lane CR, Kwong JC, Schultz M, Sait M, Stevens K, Ballard S, Gonçalves da Silva A, Seemann T, Gorrie CL, et al: Genomics for molecular epidemiology and detecting transmission of carbapenemase-producing Enterobacterales in Victoria, Australia, 2012 to 2016. J Clin Microbiol. 57:e00573–19. 2019.PubMed/NCBI View Article : Google Scholar

29 

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, Cantón R, Carmeli Y, Friedrich AW, Giske CG, et al: Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): A prospective, multinational study. Lancet Infect Dis. 17:153–163. 2017.PubMed/NCBI View Article : Google Scholar

30 

Lixandru BE, Cotar AI, Straut M, Usein CR, Cristea D, Ciontea S, Tatu-Chitoiu D, Codita I, Rafila A, Nica M, et al: Carbapenemase-producing Klebsiella pneumoniae in Romania: A six-month survey. PLoS One. 10(e0143214)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
Copy and paste a formatted citation
Spandidos Publications style
Vlad N, Dumea E, Cambrea C, Puscasu C, Ionescu C, Averian B, Mihai R, Dumitru A and Dumitru I: Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit. Med Int 3: 30, 2023.
APA
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B. ... Dumitru, I. (2023). Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit. Medicine International, 3, 30. https://doi.org/10.3892/mi.2023.90
MLA
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B., Mihai, R., Dumitru, A., Dumitru, I."Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit". Medicine International 3.3 (2023): 30.
Chicago
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B., Mihai, R., Dumitru, A., Dumitru, I."Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit". Medicine International 3, no. 3 (2023): 30. https://doi.org/10.3892/mi.2023.90
Copy and paste a formatted citation
x
Spandidos Publications style
Vlad N, Dumea E, Cambrea C, Puscasu C, Ionescu C, Averian B, Mihai R, Dumitru A and Dumitru I: Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit. Med Int 3: 30, 2023.
APA
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B. ... Dumitru, I. (2023). Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit. Medicine International, 3, 30. https://doi.org/10.3892/mi.2023.90
MLA
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B., Mihai, R., Dumitru, A., Dumitru, I."Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit". Medicine International 3.3 (2023): 30.
Chicago
Vlad, N., Dumea, E., Cambrea, C., Puscasu, C., Ionescu, C., Averian, B., Mihai, R., Dumitru, A., Dumitru, I."Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit". Medicine International 3, no. 3 (2023): 30. https://doi.org/10.3892/mi.2023.90
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team